Meta Platforms Inc. (META)

Meta Platforms is trading at $641.69, just above its 200-day average of $630.77 and about 1.7% over it, after the stock closed above that level on November 13, 2026 for the first time since November 10, 2026. The stock is still 5.61% below its 50-day average of $679.81 and 17.71% below its 52-week high, so the trend picture is mixed. CleaRank rates the stock Buy with a score of 62/100, up from 59/100 on November 12, 2026, when the rating was Hold. The score is lifted most by analysts' outlook and held back most by momentum, which is in negative territory with the MACD line negative. The business is growing faster than its sector and carries a strong balance sheet, but its last three earnings reports each produced a first-session share price drop.

META closed above its 200-day average of $630.77 on November 13, 2026, the first close above that line since November 10, 2026. The stock rose 2.90% that session on volume 17.5% below its average, and it is up 5.17% over one week. Against that, the stock fell 13.00% over one month and is still 5.61% below its 50-day average, so the short-term rebound has not yet repaired the broader downtrend. The 20-day exponential average at $642.80 sits just above the price, which means the stock is close to a level that would signal a firmer short-term footing.

The October 21, 2026 report showed adjusted EPS of $3.83 against an analyst estimate of $5.42, a miss of 29.34%, and the stock fell 6.98% in the first session after it. The July 29, 2026 report also missed, with EPS of $6.18 against $7.22, and the stock fell 7.95% the next session. The April 29, 2026 report beat by 7.18%, yet the stock still fell 8.55% in the first session. Across the seven reports on the record, five beat the estimate and two missed, and the share price was lower in the first session after four of them. The October 29, 2025 report produced the largest first-session drop on the record, 11.33%, despite a beat of 8.70%. For investors, this pattern means the stock has reacted more to the outlook than to the headline EPS number.

The trailing P/E of 21.28 is broadly in line with peers and 8.7% below the sector median of 23.3. The price-to-sales ratio of 6.79 is well above the sector median of 2.5, which reflects the market paying a premium for the company's margins. The net profit margin is 31.1%, the operating margin is 37.78%, and return on equity is 32.26%, against a sector median of 15.8%. Debt-to-equity is 0.42. Revenue grew 27.96% in the latest quarter, against a sector median of 13.9%. Analysts expect EPS of $29.12 this fiscal year and $33.97 next year, which implies the company's earnings are expected to keep growing, though the stock has not priced that growth at a premium to its sector on earnings.

Of 61 analysts with a current rating, 54 rate the stock buy or strong buy, six hold, and one sell or strong sell. Three months ago, 55 of 62 ratings were buy. On October 22, 2026, UBS, Citigroup, and DA Davidson kept Buy ratings, Evercore ISI Group and Mizuho kept Outperform ratings, and BMO Capital kept its Market Perform rating. Insiders sold $623.0M of stock over the last 18 months across 177 sales and made no open-market purchases. Those sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than purchases would be.

The base case is that the stock keeps trading between its 200-day average and its 50-day average while the market weighs strong revenue growth against the recent earnings record. Revenue grew 27.96% in the latest quarter compared with the same quarter a year earlier, and analysts expect revenue to grow 27.8% this fiscal year and EPS to grow 24.0%. For the stock to move higher with conviction, it would need to hold above the 200-day average and reclaim the 50-day average of $679.81, which would put the 52-week high of $779.82 in view. Analysts' 12-month targets run from $629.06 to $1,050.00, with a median of $850.00. The downside case is a close below the 200-day average at $630.77, which would bring the 52-week low of $520.26 back into view. Another EPS miss, like the October 21, 2026 report that came in 29.34% below the estimate, would test that support. Simulations from past volatility are not forecasts, but the typical daily move of 2.45% means the stock can travel well beyond these levels within weeks.

Support sits first at the 200-day average of $630.77, which the price cleared on November 13, 2026 and which is the closest level below the price. Below it, the 52-week low of $520.26 is the deeper floor and marks the lowest point of the past year. Resistance starts with the 20-day exponential average at $642.80, which is just above the current price. Next is the 50-day simple average at $679.81, a level the stock has been below for a while and that would confirm a shift in the trend. The 52-week high of $779.82 is the furthest level above the price and the ceiling of the past year's range.